OcrelizumabCOVID-19 infection: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1950卷 / 1期

关键词：

D O I：

10.1007/s40278-023-36718-6

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：321 / 321

相关论文

共 50 条

[21] Multiple drugsCovid-19 infection and lack of efficacy: 2 case reports
Reactions Weekly, 2025, 2050 (1) : 355 - 355
[22] ImmunosuppressantsCOVID-19 infection: 4 case reports
Reactions Weekly, 2021, 1859 (1) : 189 - 189
[23] ImmunosuppressantsCOVID-19 infection: 10 case reports
Reactions Weekly, 2021, 1841 (1) : 126 - 127
[24] ImmunosuppressantsCOVID-19 infection: 52 case reports
Reactions Weekly, 2021, 1877 (1) : 192 - 192
[25] RituximabCOVID-19 infection: 3 case reports
Reactions Weekly, 2021, 1846 (1) : 283 - 283
[26] ImmunosuppressantsCOVID-19 infection: 4 case reports
Reactions Weekly, 2021, 1845 (1) : 205 - 206
[27] RituximabCOVID-19 infection: 8 case reports
Reactions Weekly, 2021, 1872 (1) : 440 - 440
[28] ImmunosuppressantsCOVID-19 infection: 18 case reports
Reactions Weekly, 2020, 1819 (1) : 144 - 144
[29] LeflunomideCOVID-19 infection: 4 case reports
Reactions Weekly, 2021, 1861 (1) : 179 - 179
[30] AntineoplasticsCOVID-19 infection: 3 case reports
Reactions Weekly, 2022, 1888 (1) : 49 - 49

← 1 2 3 4 5 →